{
    "2018-08-09": [
        [
            {
                "time": "2018-07-31",
                "original_text": "ICU Medical, Inc. (ICUI) Q2 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Q2 earnings",
                        "conference call",
                        "transcript"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "Sangamo Therapeutics Rose despite Q2 Sales Miss, Higher Losses",
                "features": {
                    "keywords": [
                        "Sangamo Therapeutics",
                        "Q2 sales miss",
                        "higher losses"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "Why Sangamo Therapeutics, Inc. Stock Is Popping Today",
                "features": {
                    "keywords": [
                        "Sangamo Therapeutics",
                        "stock popping"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "Cabozantinib Expected to Be Exelixis’s Long-Term Growth Driver",
                "features": {
                    "keywords": [
                        "Cabozantinib",
                        "Exelixis",
                        "long-term growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-03",
                "original_text": "Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well",
                "features": {
                    "keywords": [
                        "Aerie",
                        "earnings miss",
                        "Rhopressa"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "ophthalmology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-04",
                "original_text": "Why Amgen is a Top Socially Responsible Dividend Stock (AMGN)",
                "features": {
                    "keywords": [
                        "Amgen",
                        "socially responsible",
                        "dividend stock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-06",
                "original_text": "Analysts’ Recommendations for Pfizer on August 6",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "analysts recommendations"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-06",
                "original_text": "Examining Pfizer’s Valuation as of August 6",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "valuation"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-07",
                "original_text": "A Look at Recent Developments at Pfizer",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "recent developments"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}